| Nome |
# |
|
Anisakis pegreffii impacts differentiation and function of human dendritic cells, file e383531a-4334-15e8-e053-a505fe0a3de9
|
275
|
|
Immunohistochemical characterization of immune infiltrate in tumor microenvironment of glioblastoma, file e3835327-d6cb-15e8-e053-a505fe0a3de9
|
208
|
|
The microbiota impact. bacteria shaping immunity, disease and response to therapy, file e383531b-512e-15e8-e053-a505fe0a3de9
|
184
|
|
Metastatic renal cell carcinoma management: from molecular mechanism to clinical practice, file e383532d-7afe-15e8-e053-a505fe0a3de9
|
182
|
|
CAR-T with License to Kill Solid Tumors in Search of a Winning Strategy, file e3835321-54b5-15e8-e053-a505fe0a3de9
|
181
|
|
Network analysis of gut microbiome and metabolome to discover microbiota-linked biomarkers in patients affected by non-small cell lung cancer, file e3835328-e818-15e8-e053-a505fe0a3de9
|
177
|
|
The role of soluble LAG3 and soluble immune checkpoints profile in advanced head and neck cancer: a pilot study, file e383532c-5590-15e8-e053-a505fe0a3de9
|
160
|
|
Tumor-derived microvesicles modulate antigen cross-processing via reactive oxygen species-mediated alkalinization of phagosomal compartment in dendritic cells, file e3835318-1f1a-15e8-e053-a505fe0a3de9
|
158
|
|
null, file e383531b-c05d-15e8-e053-a505fe0a3de9
|
140
|
|
Bevacizumab-based chemotherapy triggers immunological effects in responding multi-treated recurrent ovarian cancer patients by favoring the recruitment of effector t cell subsets, file e3835320-4750-15e8-e053-a505fe0a3de9
|
132
|
|
The impact of locoregional treatment on response to Nivolumab in advanced platinum refractory head and neck cancer: the NEED TRIAL, file e3835325-4ef0-15e8-e053-a505fe0a3de9
|
125
|
|
Triple peptide vaccination as consolidation treatment in women affected by ovarian and breast cancer: clinical and immunological data of a phase I/II clinical trial, file e3835314-69d9-15e8-e053-a505fe0a3de9
|
124
|
|
Can IDO activity predict primary resistance to anti-PD-1 treatment in NSCLC?, file e383531b-c1f9-15e8-e053-a505fe0a3de9
|
123
|
|
Microvesicle cargo of tumor-associated MUC1 to dendritic cells allows cross-presentation and specific carbohydrate processing., file e3835311-cfe3-15e8-e053-a505fe0a3de9
|
119
|
|
Tumor derived Microvesicles enhance cross-processing ability of clinical grade Dendritic Cells, file e383531e-535c-15e8-e053-a505fe0a3de9
|
116
|
|
Immune effects of CDK4/6 inhibitors in patients with HR+/HER2− metastatic breast cancer: relief from immunosuppression is associated with clinical response, file e383532e-6f7a-15e8-e053-a505fe0a3de9
|
116
|
|
The agnostic role of site of metastasis in predicting outcomes in cancer patients treated with immunotherapy, file e3835325-ea59-15e8-e053-a505fe0a3de9
|
114
|
|
The macrophage Galactose-type C-type Lectin (MGL) modulates regulatory T cell functions, file e3835312-b7e3-15e8-e053-a505fe0a3de9
|
113
|
|
TK inhibitor pazopanib primes DCs by downregulation of the β-catenin pathway, file e383531e-56a9-15e8-e053-a505fe0a3de9
|
112
|
|
Transplantation of human fetal biliary tree stem/progenitor cells into two patients with advanced liver cirrhosis., file e3835312-62c5-15e8-e053-a505fe0a3de9
|
109
|
|
Immunological backbone of uveal melanoma: is there a rationale for immunotherapy?, file e3835322-fdce-15e8-e053-a505fe0a3de9
|
104
|
|
Cross-talk between microbiota and immune fitness to steer and control response to anti PD-1/PDL-1 treatment, file e3835317-5c76-15e8-e053-a505fe0a3de9
|
90
|
|
A nomogram to predict survival in non-small cell lung cancer patients treated with nivolumab, file e3835322-fdd0-15e8-e053-a505fe0a3de9
|
90
|
|
MGL receptor and immunity: when the ligand can make the difference, file e3835313-fd7c-15e8-e053-a505fe0a3de9
|
84
|
|
Investigating patterns of immune interaction in ovarian cancer: probing the O-glycoproteome by the macrophage galactose-like C-type Lectin (MGL), file e3835327-9c19-15e8-e053-a505fe0a3de9
|
83
|
|
Cancer immunotherapy in patients with brain metastases, file e3835322-4372-15e8-e053-a505fe0a3de9
|
82
|
|
The sexist behaviour of immune checkpoint inhibitors in cancer therapy?, file e3835323-4c50-15e8-e053-a505fe0a3de9
|
82
|
|
Anti–PD-1 and Anti–PD-L1 in head and neck cancer: a network meta-analysis, file e383532c-ea40-15e8-e053-a505fe0a3de9
|
65
|
|
IgM-Rheumatoid factor confers primary resistance to anti-PD-1 immunotherapies in NSCLC patients by reducing CD137 + T-cells, file e3835328-7404-15e8-e053-a505fe0a3de9
|
64
|
|
Gut metabolomics profiling of non-small cell lung cancer (NSCLC) patients under immunotherapy treatment, file e3835325-06eb-15e8-e053-a505fe0a3de9
|
60
|
|
Circulating immune profile can predict survival of metastatic uveal melanoma patients: results of an exploratory study, file e383532e-5d1e-15e8-e053-a505fe0a3de9
|
60
|
|
Tryptophan Catabolism as Immune Mechanism of Primary Resistance to Anti-PD-1, file e3835327-d2c9-15e8-e053-a505fe0a3de9
|
59
|
|
Multicentre harmonisation of a six-colour flow cytometry panel for naïve/memory T cell immunomonitoring, file e3835325-4aa9-15e8-e053-a505fe0a3de9
|
57
|
|
Exploratory pilot study of circulating biomarkers in metastatic renal cell carcinoma, file e3835327-aa1d-15e8-e053-a505fe0a3de9
|
54
|
|
null, file e3835329-7174-15e8-e053-a505fe0a3de9
|
50
|
|
Glycan-Lectin Interactions as Novel Immunosuppression Drivers in Glioblastoma, file e383532e-d253-15e8-e053-a505fe0a3de9
|
45
|
|
Circulating CD137 + T cells correlate with improved response to anti-PD1 immunotherapy in cancer patients, file e383532e-2f12-15e8-e053-a505fe0a3de9
|
40
|
|
null, file e3835328-2ee0-15e8-e053-a505fe0a3de9
|
32
|
|
null, file 98116d17-25ee-4d66-9ac8-fc5d53cf6802
|
23
|
|
Genomic and immune approach in platinum refractory HPV-negative head and neck squamous cell carcinoma patients treated with Immunotherapy: a novel combined profile, file a7068b0a-e562-42be-8caf-72cfb3183f3d
|
21
|
|
The role of immune profile in predicting outcomes in cancer patients treated with immunotherapy, file e01ed9e7-9e05-4156-bfb5-bb589f98bd58
|
21
|
|
Soluble Immune checkpoints, gut metabolites and performance status as parameters of response to Nivolumab treatment in NSCLC patients, file e3835329-aa22-15e8-e053-a505fe0a3de9
|
19
|
|
Circulating CD137+ T cell levels are correlated with response to pembrolizumab treatment in advanced head and neck cancer patients, file 74c2b941-c7e1-448b-bb4c-f2696e752cee
|
15
|
|
Immunogenic cell death and immunomodulatory effects of cabozantinib, file e383532f-1363-15e8-e053-a505fe0a3de9
|
12
|
|
Immune-related toxicity and soluble profile in patients affected by solid tumors: a network approach, file 0bedcce7-5b61-45ee-b557-7de4e188289d
|
11
|
|
Human decay accelerating factor transgenic pigs for xenotransplantation obtained by sperm-mediated gene transfer, file e3835312-297d-15e8-e053-a505fe0a3de9
|
10
|
|
Cancer testis antigen expression in primary and recurrent vulvar cancer: Association with prognostic factors, file e3835311-a3e9-15e8-e053-a505fe0a3de9
|
9
|
|
Regulated expression of MUC1 epithelial antigen in erythropoiesis, file e3835312-1083-15e8-e053-a505fe0a3de9
|
9
|
|
Human duodenal submucosal glands contain a defined stem/progenitor subpopulation with liver-specific regenerative potential, file bf6d23b3-f00d-4f00-abe3-f8edbb48e11c
|
7
|
|
A network approach to define the predictive role of immune profile on tumor response and toxicity of anti PD-1 single agent immunotherapy in patients with solid tumors, file d9ae414c-947d-4fee-9e1d-4c011c1d7462
|
7
|
|
Immunological and clinical impact of cancer stem cells in vulvar cancer: role of CD133/CD24/ABCG2-Expressing Cells, file e3835315-7f05-15e8-e053-a505fe0a3de9
|
6
|
|
Immune profile of metastatic uveal melanoma during treatment with pembrolizumab, file e3835322-c81c-15e8-e053-a505fe0a3de9
|
6
|
|
The role of growth factor administration and T-cell recovery after peripheral blood progenitor cell transplantation in the treatment of solid tumors: results from a randomized comparison of G-CSF and GM-CSF., file e3835323-13e9-15e8-e053-a505fe0a3de9
|
6
|
|
Incorporating parp-inhibitors in primary and recurrent ovarian cancer. A meta-analysis of 12 phase II/III randomized controlled trials, file e383532a-6609-15e8-e053-a505fe0a3de9
|
6
|
|
Network analysis to determine association between immuno-related toxicities and immune soluble profile in patients treated with anti-PD-1, file 30d0ac26-b94f-4eec-a7e4-2299033d0974
|
5
|
|
Transfected human dendritic cells to induce antitumor immunity, file e3835311-8137-15e8-e053-a505fe0a3de9
|
5
|
|
Interaction between treg cells and angiogenesis: A dark double track, file e3835312-29d9-15e8-e053-a505fe0a3de9
|
5
|
|
Exosomes factory: a new strategy for antitumour vaccines, file e3835312-3645-15e8-e053-a505fe0a3de9
|
5
|
|
Immunomodulatory effects of tyrosine kinase inhibitors (TKIs) in renal cell carcinoma (RCC) patients, file e3835329-9f9e-15e8-e053-a505fe0a3de9
|
5
|
|
Death from Metastatic Donor-Derived Ovarian Cancer in a Male Kidney Transplant Recipient, file e3835311-c33b-15e8-e053-a505fe0a3de9
|
4
|
|
Immune effects of trastuzumab., file e3835312-5b7b-15e8-e053-a505fe0a3de9
|
4
|
|
Tumor associated MUC1 carried by microvesicles is cross-processed by dendritic cells generating CD8+ T cell response, file e3835312-b5a7-15e8-e053-a505fe0a3de9
|
4
|
|
Preliminary results of a triple peptide escalating dose vaccination phase I/II clinical trial as consolidation treatment in women affected by ovarian cancer, file e3835312-b61f-15e8-e053-a505fe0a3de9
|
4
|
|
The prognostic impact of cancer stem-like cell biomarker aldehyde dehydrogenase-1 (ALDH1) in ovarian cancer. A meta-analysis, file e383531a-ce1e-15e8-e053-a505fe0a3de9
|
4
|
|
The 5-Ws of immunotherapy in head and neck cancer, file e3835327-6450-15e8-e053-a505fe0a3de9
|
4
|
|
HUMAN DUODENAL SUBMUCOSAL GLANDS CONTAIN STEM CELLS WITH POTENTIAL FOR LIVER AND PANCREATIC FATES, file e383532d-1363-15e8-e053-a505fe0a3de9
|
4
|
|
Seasonal modulation of the C-type lectin MGL on human DCs, file e3835311-cf2f-15e8-e053-a505fe0a3de9
|
3
|
|
Monoclonal antibodies in gynecological cancer: a critical point of view., file e3835312-0fb5-15e8-e053-a505fe0a3de9
|
3
|
|
Evidence for multipotent endodermal stem/progenitor cell populations in human gallbladder, file e383531b-7ee4-15e8-e053-a505fe0a3de9
|
3
|
|
MAIALI TRANSGENICI PER hDAF: UNA POSSIBILE FONTE DI ORGANI PER XENOTRAPIANTO, file e3835311-a861-15e8-e053-a505fe0a3de9
|
2
|
|
hDAF TRANSGENIC PIG GENERATION: A NEW SOURCE OF ORGANS FOR XENOTRANSPLANTATION, file e3835311-a865-15e8-e053-a505fe0a3de9
|
2
|
|
IgM-rheumatoid factor as a novel biomarker for a reduced survival in anti-PD-1 treated NSCLC patients through the decrease of CD137+T-cells, file e3835329-9f9c-15e8-e053-a505fe0a3de9
|
2
|
|
null, file e383532d-1d4c-15e8-e053-a505fe0a3de9
|
2
|
|
Membrane and Soluble CD137 in Systemic Lupus Erythematosus: Role as Biomarkers for Disease Activity, file 1844804d-00a7-4251-ad03-2b7c5c31ed3e
|
1
|
|
Macrophage galactose-like lectin mediated interactions: investigating immunosuppressive mechanisms in glioblastoma, file ae3b6038-2176-46a2-a308-957598b17f1c
|
1
|
|
Adoptive immunotherapy with cytokine-induced killer cells generated with a new good manufacturing practice-grade protocol, file e3835312-0272-15e8-e053-a505fe0a3de9
|
1
|
|
Current knowledge and open issues regarding Bevacizumab in gynaecological neoplasms, file e3835312-1eea-15e8-e053-a505fe0a3de9
|
1
|
|
Targeting of macrophage galactose-type C-type lectin (MGL) induces DC signaling and activation, file e3835312-5b8c-15e8-e053-a505fe0a3de9
|
1
|
|
Characterisation of tumour microvessel density during progression of high-grade serous ovarian cancer: clinico-pathological impact (an OCTIPS Consortium study), file e383531c-0685-15e8-e053-a505fe0a3de9
|
1
|
|
CD137+ and regulatory T cells as independent prognostic factors of survival in advanced non-oncogene addicted NSCLC patients treated with immunotherapy as first-line, file e441e9e3-29ba-4732-9f45-273421b550ce
|
1
|
| Totale |
4.434 |